TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 0 | 3 | -10 | -15 | -43 | 0 | -16 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/31/24 18:29 | 1/29/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P.m | 387 | 3.87 | 0 | 100 | 69 | 244 | D | ||||||||||||||
12/12/22 20:00 | 12/8/22 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | P | 116 | 2.10 | 0 | 55 | 62 | 144 | D | ||||||||||||||
4/18/16 17:24 | 4/14/16 | ATNM | Actinium Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | D | P.dm | 6 | 2.02 | 1 | 3 | New | 3 | D | -83 | -38 | -10 | -4 | -1 | -1 | -1 | -1 | 0 | 3 | -10 | -15 | -43 | ||
12/17/15 09:36 | 12/15/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | P | 58 | 3.05 | 0 | 19 | 6 | 339 | D | ||||||||||||||
12/16/15 16:25 | 12/14/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | P | 0 | 2.97 | 0 | 0 | 0 | 320 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |